Search - tctmd.com

Displaying 81 - 100 of 100

Sort: Relevancy | Date

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

L.A. McKeown

November 29, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Conference News SCAI 2018

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

Todd Neale

April 27, 2018

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

L.A. McKeown

April 26, 2018

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

Caitlin E. Cox

March 11, 2018

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

Shelley Wood

January 01, 2018

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Conference News ESC 2017

Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI

Shelley Wood

September 01, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Michael O'Riordan

September 30, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

Newly Launched ACC Public Reporting Program Includes PCI Metrics, But No Mortality…For Now

L.A. McKeown

November 06, 2015

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

Advertisement

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

The Biggest News of 2017: TCTMD’s Top 10

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

New Performance and Quality Metrics for STEMI and NSTEMI Care

Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI

ESC Updates Guidelines for Treating STEMI Patients

TCTMD’s Top 10 Most Popular Stories for May 2017

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Newly Launched ACC Public Reporting Program Includes PCI Metrics, But No Mortality…For Now

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content